No Data
Earnings Preview: MediWound to Report Financial Results Pre-market on November 26
MediWound to Discuss New Share Incentive Plan
MediWound to Report Third Quarter 2024 Financial Results
MediWound's (NASDAQ:MDWD) Investors Will Be Pleased With Their Stellar 125% Return Over the Last Year
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $28